Search - tctmd.com

Displaying 401 - 420 of 563

Sort: Relevancy | Date

News Industry News

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

October 25, 2012

News Industry News

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

October 25, 2012

News Industry News

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

October 24, 2012

News Conference News TCT 2012

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

October 24, 2012

News Industry News

Nitinol Stent Performs Better Than Balloon Angioplasty Alone in Treating Lesions of the Popliteal Artery

October 24, 2012

News Industry News

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

October 24, 2012

News Conference News TCT 2012

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

October 24, 2012

Presentation TCT 2012

TCT-43. Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

Presenter: A. Pieter Kappetein

October 23, 2012

News Conference News TCT 2012

VERDICT/F1RST Confirms Modest Correlation Between IVUS, MLA and FFR

October 23, 2012

News Conference News TCT 2012

New Results from SYNTAX, SPIRIT Trials Presented

October 22, 2012

News Conference News TCT 2012

Israeli Innovations Include ‘Cath Lab of the Future,’ Stent and Digital Developments

October 22, 2012

News Industry News

IDEV Presents Consistent Evidence Validating the Mimetic Design of SUPERA® Stent

October 22, 2012

News Conference News TCT 2012

COURAGE, FAME: Revascularization More Effective Than OMT

October 22, 2012

News Industry News

First Patient Enrolled in GORE® Septal Occluder Clinical Study for Atrial Septal Defect

October 19, 2012

News Daily News

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

October 19, 2012

News Daily News

Revascularization After CTA Confers Mortality Benefit in Stable Patients at High Risk

L.A. McKeown

October 15, 2012

News Daily News

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

October 12, 2012

News Daily News

Post-PCI Stress Testing Trends Downward

October 09, 2012

News Daily News

Many Factors Contributed Toward Periprocedural Stroke in SAMMPRIS Trial

September 21, 2012

Presentation

Optimal Anticoagulant/Antiplatelet Therapy in Challenging Subsets: A Post-ESC Late Breaking Trial Roundup

Presenter: 62744|Gregg Stone

September 18, 2012

Advertisement

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

Nitinol Stent Performs Better Than Balloon Angioplasty Alone in Treating Lesions of the Popliteal Artery

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

TCT-43. Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

VERDICT/F1RST Confirms Modest Correlation Between IVUS, MLA and FFR

New Results from SYNTAX, SPIRIT Trials Presented

Israeli Innovations Include ‘Cath Lab of the Future,’ Stent and Digital Developments

IDEV Presents Consistent Evidence Validating the Mimetic Design of SUPERA® Stent

COURAGE, FAME: Revascularization More Effective Than OMT

First Patient Enrolled in GORE® Septal Occluder Clinical Study for Atrial Septal Defect

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

Revascularization After CTA Confers Mortality Benefit in Stable Patients at High Risk

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

Post-PCI Stress Testing Trends Downward

Many Factors Contributed Toward Periprocedural Stroke in SAMMPRIS Trial

Optimal Anticoagulant/Antiplatelet Therapy in Challenging Subsets: A Post-ESC Late Breaking Trial Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content